✦ LIBER ✦

Access to Essential Drugs Prevented by Pharmaceutical Multinationals

Book ID: 108572315
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 44 KB
Volume: 1
Category: Article
ISSN: 1471-8731
DOI: 10.1111/1471-8847.t01-1-00002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Access to Essential Drugs

📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB

Patents and access to essential drugs

✍ Bebe Loff 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 540 KB

Access to Essential Drugs: Latin America

Access to Essential Drugs: Latin America, South Africa, Kenya

📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Access to essential drugs in Guyana: a p

Access to essential drugs in Guyana: a public health challenge

✍ Enrique Seoane-Vazquez; Rosa Rodriguez-Monguio 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

## Abstract Guyana's pharmaceutical sector faces major challenges that limit access to essential drugs. This study analyzes Guyana's drug policy and regulation, public financing, and drug procurement and delivery. The study also identifies main barriers to drug access and proposes alternatives to s

Access to Essential Drugs: South Africa,

Access to Essential Drugs: South Africa, USA, Thailand, Europe, Philippines

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB

Access to data from clinical trials spon

Access to data from clinical trials sponsored by pharmaceutical companies

✍ ROBERT WEST 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB